Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Roger N Farah. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Roger N Farah har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:PGR / The Progressive Corporation | Director | 1 301 |
US:CVS / CVS Health Corporation | Director | 50 125 |
US:US886546AB67 / Tiffany & Co. Bond | Director | 0 |
US:AET / Aetna, Inc. | Director | 0 |
US:RL / Ralph Lauren Corporation | Executive Vice Chairman, Director | 0 |
Director | 18 177 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Roger N Farah. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Roger N Farah som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-12 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 1 301 | 1 301 | |||||
2025-04-15 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −1 715 | 0 | −100,00 | ||||
2024-12-03 |
|
4 | CVS |
CVS HEALTH Corp
Common Stock (Restricted) |
A - Award | 50 125 | 50 125 | 59,85 | 2 999 981 | 2 999 981 | ||
2024-07-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
G - Gift | −2 500 | 1 715 | −59,31 | ||||
2024-07-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
S - Sale | −5 039 | 4 215 | −54,45 | 226,67 | −1 142 278 | 955 414 | |
2024-05-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 1 715 | 9 254 | 22,75 | ||||
2024-04-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −2 549 | 7 539 | −25,27 | ||||
2023-05-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 2 549 | 10 088 | 33,81 | ||||
2023-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −3 098 | 7 539 | −29,12 | ||||
2022-05-18 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 3 098 | 10 637 | 41,09 | ||||
2022-05-13 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 3 113 | 17 084 | 22,28 | 97,99 | 305 000 | 1 674 034 | |
2022-04-18 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 119 | 133 305 | 0,09 | ||||
2022-04-11 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 3 090 | 133 187 | 2,38 | ||||
2022-04-11 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −3 090 | 7 539 | −29,07 | ||||
2022-01-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 119 | 130 097 | 0,09 | ||||
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 1 848 | 129 978 | 1,44 | ||||
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
L - Other | 8 | 10 629 | 0,08 | 90,04 | 753 | 957 020 | |
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
L - Other | 8 | 10 621 | 0,07 | 94,97 | 752 | 1 008 673 | |
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
L - Other | 7 | 7 523 | 0,10 | 100,25 | 752 | 754 167 | |
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
L - Other | 8 | 11 623 | 0,07 | 94,90 | 751 | 1 102 981 | |
2021-12-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
P - Purchase | 8 | 11 615 | 0,07 | 97,48 | 750 | 1 132 154 | |
2021-11-19 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 1 672 | 13 899 | 13,67 | 92,73 | 155 000 | 1 288 875 | |
2021-10-18 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 141 | 128 130 | 0,11 | ||||
2021-07-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 138 | 127 989 | 0,11 | ||||
2021-05-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 3 090 | 10 590 | 41,20 | ||||
2021-05-14 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 1 839 | 12 087 | 17,95 | 84,27 | 155 000 | 1 018 597 | |
2021-04-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 128 | 127 851 | 0,10 | ||||
2021-04-09 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 4 107 | 127 723 | 3,32 | ||||
2021-04-09 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −4 107 | 7 500 | −35,38 | ||||
2021-01-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 5 771 | 123 616 | 4,90 | ||||
2021-01-11 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
D - Sale to Issuer | −6 749 | 0 | −100,00 | ||||
2021-01-11 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
D - Sale to Issuer | −8 395 | 0 | −100,00 | ||||
2021-01-11 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
D - Sale to Issuer | −9 489 | 0 | −100,00 | ||||
2021-01-11 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
D - Sale to Issuer | −10 000 | 0 | −100,00 | 131,50 | −1 315 000 | ||
2021-01-11 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
D - Sale to Issuer | −25 409 | 0 | −100,00 | 131,50 | −3 341 284 | ||
2020-11-20 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 2 336 | 10 112 | 30,04 | 66,35 | 155 000 | 670 911 | |
2020-10-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 121 | 117 845 | 0,10 | ||||
2020-07-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 138 | 117 724 | 0,12 | ||||
2020-06-03 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
A - Award | 10 355 | 25 340 | 69,10 | ||||
2020-05-15 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 2 488 | 7 649 | 48,19 | 62,31 | 155 000 | 476 630 | |
2020-05-12 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 4 107 | 11 607 | 54,76 | ||||
2020-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 154 | 117 587 | 0,13 | ||||
2020-04-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 4 154 | 117 433 | 3,67 | ||||
2020-04-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −4 154 | 7 500 | −35,64 | ||||
2020-01-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 3 441 | 113 279 | 3,13 | ||||
2019-11-22 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 2 069 | 5 081 | 68,68 | 74,92 | 155 000 | 380 677 | |
2019-10-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 146 | 109 838 | 0,13 | ||||
2019-07-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 130 | 109 692 | 0,12 | ||||
2019-06-06 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
A - Award | 9 489 | 9 489 | |||||
2019-06-06 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
A - Award | 2 148 | 14 902 | 16,84 | ||||
2019-05-20 |
|
4 | CVS |
CVS HEALTH Corp
Share Credits |
A - Award | 2 964 | 2 964 | 52,30 | 155 000 | 155 000 | ||
2019-05-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 4 154 | 11 654 | 55,39 | ||||
2019-04-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 151 | 109 562 | 0,14 | ||||
2019-04-15 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 4 821 | 109 411 | 4,61 | ||||
2019-04-15 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −4 821 | 7 500 | −39,13 | ||||
2019-02-12 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 3 696 | 104 590 | 3,66 | ||||
2018-11-30 | 3 | CVS |
CVS HEALTH Corp
Common Stock |
7 642 | ||||||||
2018-11-30 | 3 | CVS |
CVS HEALTH Corp
Common Stock |
7 642 | ||||||||
2018-11-30 | 3 | CVS |
CVS HEALTH Corp
Common Stock |
7 642 | ||||||||
2018-11-30 |
|
4 | CVS |
CVS HEALTH Corp
Common Stock |
A - Award | 2 513 | 3 821 | 192,13 | ||||
2018-11-30 |
|
4 | CVS |
CVS HEALTH Corp
Common Stock |
A - Award | 1 308 | 1 308 | 80,27 | 104 993 | 104 993 | ||
2018-11-28 |
|
4 | AET |
AETNA INC /PA/
Deferred Restricted Stock Units |
D - Sale to Issuer | −33 730 | 0 | −100,00 | ||||
2018-11-28 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
D - Sale to Issuer | −990 | 0 | −100,00 | ||||
2018-11-28 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
2018-11-28 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
D - Sale to Issuer | −18 274 | 0 | −100,00 | ||||
2018-11-28 |
|
4 | AET |
AETNA INC /PA/
Common Stock |
D - Sale to Issuer | −3 000 | 0 | −100,00 | ||||
2018-10-01 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 164 | 18 214 | 0,91 | ||||
2018-07-02 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 181 | 17 986 | 1,02 | ||||
2018-05-29 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
A - Award | 8 395 | 8 395 | |||||
2018-05-29 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
A - Award | 1 598 | 12 754 | 14,32 | ||||
2018-05-25 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 4 821 | 12 321 | 64,28 | ||||
2018-05-22 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 990 | 990 | |||||
2018-04-13 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 6 879 | 100 894 | 7,32 | ||||
2018-04-13 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −6 879 | 7 500 | −47,84 | ||||
2018-04-02 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 197 | 17 738 | 1,12 | ||||
2018-03-29 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
P - Purchase | 10 000 | 10 000 | 97,66 | 976 628 | 976 628 | ||
2018-02-13 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 1 995 | 94 015 | 2,17 | ||||
2018-01-03 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 177 | 17 481 | 1,03 | ||||
2017-10-03 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 201 | 17 236 | 1,18 | ||||
2017-09-28 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
P - Purchase | 5 480 | 11 156 | 96,55 | 89,37 | 489 753 | 997 023 | |
2017-09-27 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
P - Purchase | 4 520 | 5 676 | 391,00 | 88,24 | 398 832 | 500 834 | |
2017-07-05 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 211 | 16 961 | 1,26 | ||||
2017-05-30 |
|
4 | TIF |
TIFFANY & CO
Non-Qualified Stock Option (Right to Buy) |
A - Award | 6 749 | 6 749 | |||||
2017-05-30 |
|
4 | TIF |
TIFFANY & CO
Common Stock $.01 Par |
A - Award | 1 156 | 1 156 | |||||
2017-05-23 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 1 203 | 1 203 | |||||
2017-05-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 6 879 | 14 379 | 91,72 | ||||
2017-04-13 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 7 973 | 92 020 | 9,49 | ||||
2017-04-13 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −7 973 | 7 500 | −51,53 | ||||
2017-04-04 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 251 | 16 171 | 1,58 | ||||
2017-03-16 | 3 | TIF |
TIFFANY & CO
No Securities Are Beneficially Owned |
0 | ||||||||
2017-02-14 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 1 500 | 84 047 | 1,82 | ||||
2017-01-04 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 258 | 15 886 | 1,65 | ||||
2016-10-04 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 277 | 15 592 | 1,81 | ||||
2016-07-05 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 262 | 15 282 | 1,74 | ||||
2016-05-24 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 1 537 | 1 537 | |||||
2016-05-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 7 973 | 15 473 | 106,31 | ||||
2016-04-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 9 732 | 82 547 | 13,37 | ||||
2016-04-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −9 732 | 7 500 | −56,48 | ||||
2016-04-04 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 285 | 14 986 | 1,94 | ||||
2016-02-16 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 2 028 | 72 815 | 2,86 | ||||
2016-01-05 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 250 | 14 666 | 1,73 | ||||
2015-10-01 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 247 | 14 385 | 1,75 | ||||
2015-07-02 |
|
4 | AET |
AETNA INC /PA/
Phantom Stock Units |
A - Award | 212 | 14 107 | 1,52 | ||||
2015-05-19 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 1 420 | 1 420 | |||||
2015-05-18 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 9 732 | 17 232 | 129,76 | ||||
2015-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 9 464 | 70 788 | 15,43 | ||||
2015-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −9 464 | 7 500 | −55,79 | ||||
2015-04-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 253 | 13 863 | 1,86 | ||||
2015-02-18 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 1 519 | 61 324 | 2,54 | ||||
2015-01-05 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 304 | 13 935 | 2,23 | ||||
2014-10-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 333 | 13 577 | 2,52 | ||||
2014-07-01 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 333 | 13 192 | 2,59 | ||||
2014-06-03 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 2 064 | 2 064 | |||||
2014-05-29 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
D - Sale to Issuer | −87 952 | 0 | −100,00 | ||||
2014-05-19 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 9 464 | 16 964 | 126,19 | ||||
2014-05-19 |
|
4/A | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 9 464 | 16 964 | 126,19 | ||||
2014-05-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −24 580 | 0 | −100,00 | ||||
2014-05-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −16 311 | 87 952 | −15,64 | 148,24 | −2 417 943 | 13 038 047 | |
2014-05-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −26 200 | 104 263 | −20,08 | 147,43 | −3 862 666 | 15 371 537 | |
2014-05-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 24 580 | 130 463 | 23,21 | 134,53 | 3 306 747 | 17 551 226 | |
2014-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 8 592 | 59 805 | 16,78 | ||||
2014-04-17 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −8 592 | 7 500 | −53,39 | ||||
2014-04-15 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 257 | 105 883 | 0,24 | ||||
2014-04-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 360 | 12 800 | 2,90 | ||||
2014-04-01 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
F - Taxes | −15 587 | 105 626 | −12,86 | 160,14 | −2 496 102 | 16 915 000 | |
2014-02-11 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit (rest. Stock) |
A - Award | 3 113 | 51 213 | 6,47 | ||||
2014-01-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 226 | 121 213 | 0,19 | ||||
2014-01-03 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 357 | 12 379 | 2,97 | ||||
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −600 | 120 987 | −0,49 | 173,57 | −104 142 | 20 999 700 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −9 000 | 121 587 | −6,89 | 172,93 | −1 556 370 | 21 026 026 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −18 540 | 37 080 | −33,33 | ||||
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −24 580 | 24 580 | −50,00 | ||||
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −44 131 | 0 | −100,00 | ||||
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −18 | 130 587 | −0,01 | 180,95 | −3 257 | 23 629 703 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −700 | 130 605 | −0,53 | 180,08 | −126 056 | 23 519 334 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −900 | 131 305 | −0,68 | 179,26 | −161 334 | 23 537 720 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −10 249 | 132 205 | −7,19 | 177,89 | −1 823 195 | 23 517 933 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −8 051 | 142 454 | −5,35 | 177,25 | −1 427 040 | 25 249 957 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −8 446 | 150 505 | −5,31 | 175,93 | −1 485 905 | 26 478 331 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −18 454 | 158 951 | −10,40 | 174,75 | −3 224 836 | 27 776 673 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −33 700 | 177 405 | −15,96 | 173,88 | −5 859 756 | 30 847 167 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −42 100 | 211 105 | −16,63 | 172,73 | −7 271 933 | 36 464 153 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
D - Sale to Issuer | −87 467 | 253 205 | −25,67 | ||||
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 18 540 | 340 672 | 5,76 | 140,98 | 2 613 676 | 48 026 224 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 24 580 | 322 132 | 8,26 | 134,53 | 3 306 747 | 43 336 407 | |
2013-11-08 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 44 131 | 297 552 | 17,41 | 75,19 | 3 318 210 | 22 372 929 | |
2013-10-15 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 429 | 253 421 | 0,17 | ||||
2013-10-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 383 | 11 964 | 3,30 | ||||
2013-07-16 |
|
4 | RL |
RALPH LAUREN CORP
Options issued purs. to 2010 Long-Term Stock Incentive Plan |
A - Award | 63 237 | 63 237 | |||||
2013-07-16 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 381 | 252 992 | 0,15 | ||||
2013-07-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 386 | 11 527 | 3,46 | ||||
2013-06-12 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
F - Taxes | −47 883 | 252 611 | −15,93 | 173,98 | −8 330 924 | 43 950 483 | |
2013-06-12 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 92 850 | 300 494 | 44,72 | ||||
2013-05-21 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 2 665 | 2 665 | |||||
2013-05-20 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 8 592 | 16 092 | 114,56 | ||||
2013-04-15 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 400 | 207 644 | 0,19 | ||||
2013-04-01 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 479 | 11 082 | 4,52 | ||||
2013-03-21 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit / (Rest. Stock) |
A - Award | 8 891 | 48 100 | 22,68 | ||||
2013-03-21 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −8 891 | 7 500 | −54,24 | ||||
2013-02-04 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit / (Rest. Stock) |
A - Award | 486 | 39 209 | 1,26 | ||||
2013-01-03 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 529 | 10 536 | 5,29 | ||||
2013-01-02 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 468 | 207 243 | 0,23 | ||||
2012-12-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −42 213 | 0 | −100,00 | ||||
2012-12-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −23 130 | 206 775 | −10,06 | 151,37 | −3 501 188 | 31 299 503 | |
2012-12-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −19 083 | 229 905 | −7,66 | 150,62 | −2 874 281 | 34 628 262 | |
2012-12-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 42 213 | 248 988 | 20,41 | 78,24 | 3 302 745 | 19 480 806 | |
2012-11-30 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit / (Rest. Stock) |
A - Award | 1 722 | 38 723 | 4,65 | 21,49 | 37 001 | 832 154 | |
2012-10-15 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 444 | 206 775 | 0,22 | ||||
2012-10-02 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 619 | 9 944 | 6,63 | ||||
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −24 580 | 49 160 | −33,33 | ||||
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock Option (Right to Buy) |
M - Exercise | −44 131 | 44 131 | −50,00 | ||||
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −4 311 | 206 331 | −2,05 | 150,06 | −646 909 | 30 962 000 | |
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −37 951 | 210 642 | −15,27 | 149,28 | −5 665 325 | 31 444 608 | |
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −26 449 | 248 593 | −9,62 | 148,81 | −3 935 876 | 36 993 095 | |
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 44 131 | 275 042 | 19,11 | 75,19 | 3 318 210 | 20 680 393 | |
2012-08-13 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
M - Exercise | 24 580 | 230 911 | 11,91 | 134,53 | 3 306 747 | 31 064 430 | |
2012-07-17 |
|
4 | RL |
RALPH LAUREN CORP
Options issued purs. to 2010 Long-Term Stock Incentive Plan |
A - Award | 55 620 | 55 620 | |||||
2012-07-17 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 494 | 206 331 | 0,24 | ||||
2012-07-03 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 623 | 9 252 | 7,22 | ||||
2012-06-14 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −11 903 | 205 837 | −5,47 | 141,10 | −1 679 513 | 29 043 602 | |
2012-06-14 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −35 097 | 217 740 | −13,88 | 140,45 | −4 929 374 | 30 581 584 | |
2012-06-14 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
S - Sale | −32 | 252 837 | −0,01 | 139,87 | −4 476 | 35 364 313 | |
2012-06-14 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
F - Taxes | −40 179 | 252 869 | −13,71 | 140,70 | −5 653 386 | 35 579 934 | |
2012-06-14 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 87 211 | 293 048 | 42,37 | ||||
2012-05-22 |
|
4 | AET |
AETNA INC /PA/
Restricted Stock Units |
A - Award | 4 079 | 4 079 | |||||
2012-04-24 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
A - Award | 8 891 | 16 391 | 118,55 | ||||
2012-04-17 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 200 | 205 837 | 0,10 | ||||
2012-04-03 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 456 | 8 570 | 5,62 | ||||
2012-04-03 |
|
4/A | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 33 518 | 205 637 | 19,47 | ||||
2012-04-02 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit / (Rest. Stock) |
A - Award | 8 660 | 37 001 | 30,56 | ||||
2012-04-02 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
D - Sale to Issuer | −8 660 | 7 500 | −53,59 | ||||
2012-02-07 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Phantom Stock Unit / (Rest. Stock) |
A - Award | 535 | 28 341 | 1,92 | 21,17 | 11 323 | 599 980 | |
2012-01-17 |
|
4 | RL |
RALPH LAUREN CORP
Class A Common Stock |
A - Award | 238 | 172 119 | 0,14 | ||||
2012-01-04 |
|
4 | AET |
AETNA INC /PA/
PHANTOM STOCK UNITS |
A - Award | 350 | 8 058 | 4,54 | ||||
2010-09-16 |
|
4 | RL |
POLO RALPH LAUREN CORP
Class A Common Stock |
S - Sale | X | −1 712 | 220 722 | −0,77 | 85,33 | −146 078 | 18 833 351 |
2010-09-16 |
|
4 | RL |
POLO RALPH LAUREN CORP
Class A Common Stock |
S - Sale | X | −21 100 | 222 434 | −8,66 | 84,66 | −1 786 432 | 18 832 400 |
2008-06-24 |
|
4/A | PGR |
PROGRESSIVE CORP/OH/
Common |
P - Purchase | 7 500 | 7 500 | 20,09 | 150 675 | 150 675 | ||
2008-06-23 |
|
4 | PGR |
PROGRESSIVE CORP/OH/
Common |
P - Purchase | 7 500 | 7 500 | 20,09 | 150 675 | 150 675 | ||
2007-06-28 | 3 | AET |
AETNA INC /PA/
Common Stock |
3 000 | ||||||||
2006-10-17 |
|
4 | RL |
POLO RALPH LAUREN CORP
Class A Common Stock |
A - Award | 185 | 505 540 | 0,04 | ||||
2003-08-08 |
|
4 | TOY |
TOYS R US INC
Common Stock |
A - Award | 2 030 | 18 177 | 12,57 | 10,96 | 22 250 | 199 234 |